Orchestra BioMed Holdings (OBIO) Operating Margin (2022 - 2025)
Historic Operating Margin for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to 2359.23%.
- Orchestra BioMed Holdings' Operating Margin fell 7035100.0% to 2359.23% in Q3 2025 from the same period last year, while for Sep 2025 it was 2669.91%, marking a year-over-year decrease of 3992200.0%. This contributed to the annual value of 2437.49% for FY2024, which is 5713300.0% down from last year.
- According to the latest figures from Q3 2025, Orchestra BioMed Holdings' Operating Margin is 2359.23%, which was down 7035100.0% from 2311.84% recorded in Q2 2025.
- In the past 5 years, Orchestra BioMed Holdings' Operating Margin registered a high of 592.15% during Q1 2022, and its lowest value of 6591.7% during Q4 2024.
- Its 4-year average for Operating Margin is 2298.8%, with a median of 2166.97% in 2024.
- Per our database at Business Quant, Orchestra BioMed Holdings' Operating Margin plummeted by -38727200bps in 2023 and then soared by 18106200bps in 2024.
- Over the past 4 years, Orchestra BioMed Holdings' Operating Margin (Quarter) stood at 891.02% in 2022, then tumbled by -435bps to 4763.74% in 2023, then crashed by -38bps to 6591.7% in 2024, then soared by 64bps to 2359.23% in 2025.
- Its Operating Margin was 2359.23% in Q3 2025, compared to 2311.84% in Q2 2025 and 2179.84% in Q1 2025.